Method choice is crucial to when seeking answers to biosimilar characterization questions.
Guillaume Tremintin
Advertisement
Guillaume Tremintin is the biopharma market manager for Bruker Daltonics.
Articles by Guillaume Tremintin
Advertisement
Latest Updated Articles
Matching Tools to Biophysical Analysis DemandsPublished: July 1st 2017 | Updated:
Advertisement
Advertisement
Trending on BioPharm International
1
Advances in Continuous Manufacturing, Drug Delivery Lead CPHI Pharma Awards 2025
2
Establishing Risk Assessments for AI in Bio-Manufacturing
3
Why Data Quality, Not Regulation, Is the True Barrier to AI in Biologics
4
Particle Risk Mitigation in Biomanucturing
5
